Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
206.19
156.45
164.07
144.00
152.81
142.24
79.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
206.19
156.45
164.07
144.00
152.81
142.24
79.44
Raw Material Cost
99.16
75.48
80.89
70.81
75.48
67.30
40.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.97
-2.85
-5.29
-0.93
-0.60
-2.73
-0.89
Employee Cost
32.36
26.38
23.71
18.21
16.14
14.05
12.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
39.02
32.01
30.47
26.40
20.79
17.49
14.14
Total Expenditure (Excl Depreciation)
167.58
131.02
129.79
114.48
111.81
96.11
65.96
Operating Profit (PBDIT) excl Other Income
38.61
25.43
34.28
29.52
41.00
46.13
13.48
Other Income
5.41
3.91
1.75
1.94
1.02
0.79
0.45
Operating Profit (PBDIT)
44.02
29.34
36.03
31.46
42.02
46.92
13.93
Interest
0.91
0.80
1.17
0.75
1.28
1.67
2.34
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-0.32
0.61
Gross Profit (PBDT)
43.11
28.54
34.86
30.71
40.74
44.93
12.20
Depreciation
4.93
4.17
3.33
2.60
2.54
2.22
1.80
Profit Before Tax
38.17
24.37
31.53
28.12
38.20
42.71
10.40
Tax
10.73
6.10
7.87
7.09
9.65
11.00
2.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
27.45
18.27
23.66
21.02
28.55
31.71
7.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
27.45
18.27
23.66
21.02
28.55
31.71
7.84
Share in Profit of Associates
2.44
3.26
1.19
3.82
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-3.22
-1.37
-0.77
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.89
21.53
24.85
24.84
25.33
30.34
7.07
Equity Capital
8.26
8.26
8.26
8.26
8.26
8.26
8.26
Face Value
2.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
173.28
145.14
125.19
101.65
90.40
60.49
30.93
Earnings per share (EPS)
7.24
5.21
30.08
30.07
30.67
36.73
8.56
Diluted Earnings per share
7.23
5.21
30.07
30.06
30.66
36.71
8.55
Operating Profit Margin (Excl OI)
18.73%
16.25%
20.89%
20.5%
26.83%
32.43%
16.97%
Gross Profit Margin
20.91%
18.24%
21.25%
21.33%
26.66%
31.59%
15.36%
PAT Margin
13.31%
11.68%
14.42%
14.6%
18.68%
22.29%
9.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 31.79% vs -4.64% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 38.83% vs -13.36% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 51.83% vs -25.82% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 13.75% vs -31.62% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Titan Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
206.19
1,276.00
-1,069.81
-83.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
206.19
1,276.00
-1,069.81
-83.84%
Raw Material Cost
99.16
764.73
-665.57
-87.03%
Purchase of Finished goods
0.00
95.05
-95.05
-100.00%
(Increase) / Decrease In Stocks
-2.97
-11.73
8.76
74.68%
Employee Cost
32.36
62.68
-30.32
-48.37%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
39.02
149.05
-110.03
-73.82%
Total Expenditure (Excl Depreciation)
167.58
1,059.78
-892.20
-84.19%
Operating Profit (PBDIT) excl Other Income
38.61
216.22
-177.61
-82.14%
Other Income
5.41
38.98
-33.57
-86.12%
Operating Profit (PBDIT)
44.02
255.20
-211.18
-82.75%
Interest
0.91
0.21
0.70
333.33%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
43.11
254.99
-211.88
-83.09%
Depreciation
4.93
8.36
-3.43
-41.03%
Profit Before Tax
38.17
246.64
-208.47
-84.52%
Tax
10.73
67.30
-56.57
-84.06%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
27.45
179.34
-151.89
-84.69%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
27.45
179.34
-151.89
-84.69%
Share in Profit of Associates
2.44
0.82
1.62
197.56%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.89
180.16
-150.27
-83.41%
Equity Capital
8.26
24.89
-16.63
-66.81%
Face Value
2.00
1.00
0.00
Reserves
173.28
1,058.34
-885.06
-83.63%
Earnings per share (EPS)
7.24
7.24
0.00
Diluted Earnings per share
7.23
7.24
-0.01
-0.14%
Operating Profit Margin (Excl OI)
18.73%
16.95%
0.00
1.78%
Gross Profit Margin
20.91%
19.98%
0.00
0.93%
PAT Margin
13.31%
14.12%
0.00
-0.81%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 206.19 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.79% vs -4.64% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 29.89 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 38.83% vs -13.36% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.61 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 51.83% vs -25.82% in Mar 2025
Annual - Interest
Interest 0.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.75% vs -31.62% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.73%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
